Sepsis: Clinical dilemmas

Yale Journal of Biology and Medicine

Volumn 71, Issue 6, 1998, Pages 485-491

  Murray, Michael J ^a  

^a MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CONFERENCE PAPER; HUMAN; HYPOTENSION; MULTIPLE ORGAN FAILURE; OXYGEN CONSUMPTION; SEPSIS; SEPTIC SHOCK; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME; SYSTEMIC VASCULAR RESISTANCE;

CARDIAC OUTPUT; CRITICAL CARE; CRITICAL ILLNESS; HUMANS; HYPOTENSION; OXYGEN CONSUMPTION; SEPSIS; SHOCK, SEPTIC;

EID: 0345580878     PISSN: 00440086     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (29)

1. Bone, R.C., Balk, R.A., Cerra, F.B., and Dellinger, R.P. Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. Chest 101:1644-1655, 1992.
2. Kollef, M.H. and Eisenberg, P.R. The relationship of the ACCP/SCCM consensus conference classification of sepsis to mortality and multiorgan dysfunction among medical ICU patients. J. Intensive Care Med. 11:326-334, 1996.
3. National Center for Health Statistics, Center for Infectious Diseases. Increase in national hospital discharge survey rates for septicemia - United States, 1979-1987. Morbidity and Mortality Weekly Report (M. M. W. R.) 38:31-34, 1989.
4. Browne, W.T., Murray, M.J., and Eisenhower, D.D. A population-based study to determine the accuracy of discharge diagnosis in patients with sepsis, severe sepsis, and septic shock. Crit. Care Med. 23:A163, 1995.
5. Pinner, R.W., Teutsch, S.M., Simonsen, L., and Klug, L.A. Trends in infectious diseases mortality in the United States. JAMA 275:189-193, 1996.
6. Werner, E., Murray, M.J., Lunn, J.J., Stoddard, S.L., Go, V.L.W., and Rorie, D.K. Neuropeptides: Plasma levels in endotoxic shock. Anesthesiology 73:A311, 1990.
7. Bradley, J.R., Wilks, D., and Rubenstein, D. The vascular endothelium in septic shock. J. Infect. 28:1-10, 1994.
8. Finley, R.J., Duff, J.H., Holliday, R.L., Jones, D., and Marchuk, J.B. Capillary muscle blood flow in human sepsis. Surgery 78:87-94, 1975.
9. Parker, M.M., Shelhamer, J.H., Bacharach, S.L., Green, M.V., Natanson, C., Frederick, T.M., Damske, B.A., and Parrillo, J.E. Profound but reversible myocardial depression in patients with septic shock. Ann. Intern. Med. 100:483-490, 1984.
10. Parrillo, J.E., Burch, C., Shelhamer, J.H., Parker, M.M., Natanson, C., and Schuette, W.A circulating myocardial depressant substance in humans with septic shock. Septic shock patients with a reduced ejection fraction have a circulating factor that depresses in vitro myocardial cell performance. J. Clin. Invest. 76:1539-1553, 1985.
11. Parker, M.M., Suffredini, A.F., Natanson, C., Ognibene, F.P., Shelhamer, J.H., and Parrillo, J.E. Responses of left ventricular function in survivors and nonsurvivors of septic shock. J. Crit. Care 4:19-25, 1989.
12. Duff, J.H., Groves, A.C., McLean, A.PH., LaPointe, R., and MacLean, L.D. Defective oxygen consumption in septic shock. Surg. Gynecol. Obstet. 128:1051-1060, 1969.
13. Shoemaker, W.C., Appel. P.L., Kram, H.B., Waxman, K., and Lee, T.-S. Prospective trial of supranormal values of survivors as therapeutic goals in high-risk surgical patients. Chest 94:1176-1186, 1988.
14. Sibbald, W.J. and Vincent. J.-L. Roundtable conference on clinical trials for the treatment of sepsis. Chest 107:522-527, 1995.
15. Archie, J.P., Jr. Mathematic coupling of data: a common source of error. Ann. Surg. 193:296-303, 1981.
16. Bone, R.C., Fisher, C.J., Clemmer, T.P., Slotman, G.J., Metz, C.A., and Balk, R.A. Methylprednisolone Severe Sepsis Study Group. A controlled clinical trial of high-dose methylprednisolone in the treatment of severe sepsis and septic shock. N. Engl. J. Med. 317:653-658, 1987.
17. The Veterans Administration Systemic Sepsis Cooperative Study Group. Effect of high-dose glucocorticoid therapy on mortality in patients with clinical signs of systemic sepsis. N. Engl. J. Med. 317:659-665, 1987.
18. Abraham, E., Glauser, M.P., Butler, T., Garbino, J., Gelmont, D., Laterre, P.F., Kudsk, K., Bruining, H.A., Otto, C., Tobin, E., Zwingelstein, C., Lesslauer, W., and Leighton, A. p55 tumor necrosis factor receptor fusion protein in the treatment of patients with severe sepsis and septic shock. A randomized controlled multicenter trial. JAMA 277:1531-1538, 1997.
19. Widmer, A.F. Infection control and prevention strategies in the ICU. Intensive Care Med. 20:S7-S11, 1994.
20. Goldmann, D. and Larson, E. Hand-washing and nosocomial infections. N. Engl. J. Med. 327:120-122, 1992.
21. Natanson, C., Danner, R.L., Reilly, J.M., Doerfler, M.L., Hoffman, W.D., Akin, G.L., Hosseini, J.M., Banks, S.M., Elin, R.J., MacVittie, T.J., and Parrillo, J.E. Antibiotics versus cardiovascular support in a canine model of human septic shock. Am. J. Physiol. 259:H1440-H1447, 1990.
22. Extermann, M. and Regamey, C. Empirical antibiotic treatment of sepsis in non-neutropenic patients: single agent or combination therapy? Infection 22:1-3, 1994.
23. Groeneveld, A.B.J., Bronsveld, W., and Thijs, L.G. Hemodynamic determinants of mortality in human septic shock. Surgery 99:140-153, 1986.
24. Petros, A., Lamb, G., Leone, A., Moncada, S., Bennett, D., and Vallance, P. Effects of a nitric oxide synthase inhibitor in humans with septic shock. Cardiovasc. Res. 28:34-39, 1994.
25. Rudis, M.I., Basha, M.A., and Zarowitz, B.J. Is it time to reposition vasopressors and inotropes in sepsis? Crit. Care Med. 24:525-537, 1996.
26. Marik, P. E. and Mohedin, M. The contrasting effects of dopamine and norepinephrine on systemic and splanchnic oxygen utilization in hyperdynamic sepsis. JAMA 272:1354-1357, 1994.
27. Reinelt, H., Radermacher, P., Fischer, G., Geisser, W., Wachter, U., Wiedeck, H., Georgieff, M., and Vogt, J. Effects of a dobutamine-induced increase in splanchnic blood flow on hepatic metabolic activity in patients with septic shock. Anesthesiology 86:818-823, 1997.
28. Vincent, J.-L., Thijs, L., Reinhart, K., Hazelzet, J., Brun-Buisson, C., Carlet, J., Le Gall, J.-R., Suter, P., Takala, J., Cohen, J., Edwards, D., Glauser, M., Gullo, A., Hemmer, M., Lamy, M., Langer, M., Rello, J., Schuster, H. P., Bihari, D., and Goris, J. The problem of sepsis. An expert report of the European Society of Intensive Care Medicine. Intensive Care Med. 20:300-304, 1994.
29. Eidelman, L.A., Pizov, R., and Sprung, C.L. New therapeutic approaches in sepsis: a critical review. Intensive Care Med. 21:S269-S272, 1995.